1. Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial. Issue 5 (May 2019) Authors: Moore, Kathleen N; Secord, Angeles Alvarez; Geller, Melissa A; Miller, David Scott; Cloven, Noelle; Fleming, Gini F; Wahner Hendrickson, Andrea E; Azodi, Masoud; DiSilvestro, Paul; Oza, Amit M; Cristea, Mihaela; Berek, Jonathan S; Chan, John K; Rimel, Bobbie J; Matei, Daniela E; Li, Yong; Sun, Ka... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer. Issue 3 (14th March 2022) Authors: Lheureux, Stephanie; Matei, Daniela E; Konstantinopoulos, Panagiotis A; Wang, Ben X; Gadalla, Ramy; Block, Matthew S; Jewell, Andrea; Gaillard, Stephanie L; McHale, Michael; McCourt, Carolyn; Temkin, Sarah; Girda, Eugenia; Backes, Floor J; Werner, Theresa L; Duska, Linda; Kehoe, Siobhan; Colombo,... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗